These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor beta signaling. Reed JA; Bales E; Xu W; Okan NA; Bandyopadhyay D; Medrano EE Cancer Res; 2001 Nov; 61(22):8074-8. PubMed ID: 11719430 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of the expression of c-Ski and SnoN, possible mediators in TGF-beta resistance, in primary cutaneous melanoma. Boone B; Haspeslagh M; Brochez L J Dermatol Sci; 2009 Jan; 53(1):26-33. PubMed ID: 18782659 [TBL] [Abstract][Full Text] [Related]
6. SKI activates Wnt/beta-catenin signaling in human melanoma. Chen D; Xu W; Bales E; Colmenares C; Conacci-Sorrell M; Ishii S; Stavnezer E; Campisi J; Fisher DE; Ben-Ze'ev A; Medrano EE Cancer Res; 2003 Oct; 63(20):6626-34. PubMed ID: 14583455 [TBL] [Abstract][Full Text] [Related]
7. Rapamycin induces the TGFbeta1/Smad signaling cascade in renal mesangial cells upstream of mTOR. Osman B; Doller A; Akool el-S; Holdener M; Hintermann E; Pfeilschifter J; Eberhardt W Cell Signal; 2009 Dec; 21(12):1806-17. PubMed ID: 19666112 [TBL] [Abstract][Full Text] [Related]
8. Clinical markers and driving mechanisms in melanoma progression: VEGF-C, RhoC, c-Ski/SnoN and EGFR. Boone B; Brochez L Verh K Acad Geneeskd Belg; 2009; 71(5):251-94. PubMed ID: 20232784 [TBL] [Abstract][Full Text] [Related]
9. Involvement of the constitutive complex formation of c-Ski/SnoN with Smads in the impaired negative feedback regulation of transforming growth factor beta signaling in scleroderma fibroblasts. Jinnin M; Ihn H; Mimura Y; Asano Y; Tamaki K Arthritis Rheum; 2007 May; 56(5):1694-705. PubMed ID: 17469184 [TBL] [Abstract][Full Text] [Related]
10. c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements. Suzuki H; Yagi K; Kondo M; Kato M; Miyazono K; Miyazawa K Oncogene; 2004 Jun; 23(29):5068-76. PubMed ID: 15107821 [TBL] [Abstract][Full Text] [Related]
14. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer. Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344 [TBL] [Abstract][Full Text] [Related]
15. Efficient TGF-β/SMAD signaling in human melanoma cells associated with high c-SKI/SnoN expression. Javelaud D; van Kempen L; Alexaki VI; Le Scolan E; Luo K; Mauviel A Mol Cancer; 2011 Jan; 10(1):2. PubMed ID: 21211030 [TBL] [Abstract][Full Text] [Related]
16. Nuclear and cytoplasmic c-Ski differently modulate cellular functions. Nagata M; Goto K; Ehata S; Kobayashi N; Saitoh M; Miyoshi H; Imamura T; Miyazawa K; Miyazono K Genes Cells; 2006 Nov; 11(11):1267-80. PubMed ID: 17054724 [TBL] [Abstract][Full Text] [Related]
17. Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines. Schuierer MM; Bataille F; Hagan S; Kolch W; Bosserhoff AK Cancer Res; 2004 Aug; 64(15):5186-92. PubMed ID: 15289323 [TBL] [Abstract][Full Text] [Related]
18. Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis. Chetoui N; Sylla K; Gagnon-Houde JV; Alcaide-Loridan C; Charron D; Al-Daccak R; Aoudjit F Mol Cancer Res; 2008 Jan; 6(1):42-52. PubMed ID: 18234961 [TBL] [Abstract][Full Text] [Related]
19. SKI is critical for repressing the growth inhibitory function of TGF-beta in human melanoma. Reed JA; Chen D; Lin Q; Medrano EE Pigment Cell Melanoma Res; 2008 Aug; 21(4):494-5; author reply 496-7. PubMed ID: 18510588 [No Abstract] [Full Text] [Related]
20. An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas. Nickl-Jockschat T; Arslan F; Doerfelt A; Bogdahn U; Bosserhoff A; Hau P Int J Oncol; 2007 Feb; 30(2):499-507. PubMed ID: 17203233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]